Delivery Order SPE2DB22D2009-SPE2DB24FM1VY

Award Date 9/5/24
Potential Completion Date 9/6/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,208.14 firm fixed-price contract is for the supply of Otezla 30 mg tablets. The contract has an ultimate completion date of September 12, 2024 and is not a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999 through December 2025 for delivering a wide...
This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,819.39 firm fixed-price contract is for the provision of Otezla 30 mg tablets. The contract has an ultimate completion date of June 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a wide range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OTEZLA 30 MG TABLET 60S. The contract has a ceiling value of $15,397.10 and is a firm fixed price delivery order contract with an ultimate completion date of October 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,597.77, is for the delivery of Otezla 30 mg tablets. The contract is a firm fixed-price, non-set-aside award with a completion date of June 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Otezla 30 mg tablets. The contract has a ceiling value of $32,649.63 and is a firm fixed-price delivery order that will run through May 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $8,178.15, is for the delivery of Otezla 30 mg tablets over a period ending on April 8, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,785.70, is for the delivery of Otezla 30mg tablets. The contract has an ultimate completion date of February 9, 2023 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $15,739.44, is for the delivery of Otezla 30 mg tablets over a period ending on April 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a $5,250.74 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for Otezla 30 mg tablets, a pharmaceutical product, with a performance period through April 9, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $10,134.54 firm-fixed-price contract is for the delivery of 4566211321 - OTEZLA 30 MG TABLET 60S, which is a prescription medication. The contract has an ultimate completion date of October 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB24FM1VY
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Otezla 30 mg tablets. The order, valued at $12,862.34, is a firm fixed-price contract with a period of performance through September 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which serves as the primary vehicle for the company to provide a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The current delivery order is not set aside for any specific business type.

Generated 12/5/24, 10:37 AM